Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Bersani, G
Obesity (Silver Spring), 2025, 1-29
Long-term safety and cardiovascular outcomes are not yet established no completed cardiovascular outcomes trial exists as of 2026 and dose-dependent increases in heart rate were observed in Phase 2, a class effect under continued study
Individual Tissue Sensitivity and Biomarker Considerations Individual variation in subcutaneous tissue sensitivity, inflammatory response capacity, and nerve density contributes to perceived injection site burning
The question is whether these specific ingredients, at the doses provided in Activate, actually trigger meaningful AMPK activation in humans
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
